These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29882046)

  • 1. Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay.
    Châtel L; Yang X; Cholette F; Soudeyns H; Sandstrom P; Lavigne C
    Arch Virol; 2018 Oct; 163(10):2701-2710. PubMed ID: 29882046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Tat/Rev Induced Limiting Dilution Assay to Measure Viral Reservoirs in Non-Human Primate Models of HIV Infection.
    Frank I; Acharya A; Routhu NK; Aravantinou M; Harper JL; Maldonado S; Sole Cigoli M; Semova S; Mazel S; Paiardini M; Derby N; Byrareddy SN; Martinelli E
    Sci Rep; 2019 Aug; 9(1):12078. PubMed ID: 31427605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Improved Tat/Rev Induced Limiting Dilution Assay With Enhanced Sensitivity and Breadth of Detection.
    Mehta K; Gohil Y; Mishra S; D'silva A; Amanullah A; Selvam D; Pargain N; Nala N; Sanjeeva GN; Ranga U
    Front Immunol; 2021; 12():715644. PubMed ID: 34421920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.
    Procopio FA; Fromentin R; Kulpa DA; Brehm JH; Bebin AG; Strain MC; Richman DD; O'Doherty U; Palmer S; Hecht FM; Hoh R; Barnard RJ; Miller MD; Hazuda DJ; Deeks SG; Sékaly RP; Chomont N
    EBioMedicine; 2015 Aug; 2(8):874-83. PubMed ID: 26425694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TILDA: Tat/Rev Induced Limiting Dilution Assay.
    Lungu C; Procopio FA
    Methods Mol Biol; 2022; 2407():365-372. PubMed ID: 34985676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA.
    Lungu C; Procopio FA; Overmars RJ; Beerkens RJJ; Voermans JJC; Rao S; Prins HAB; Rokx C; Pantaleo G; Vijver DAMCV; Mahmoudi T; Boucher CAB; Gruters RA; Kampen JJAV
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32887284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches to assess HIV-1 persistence.
    Banga R; Procopio FA; Perreau M
    Curr Opin HIV AIDS; 2016 Jul; 11(4):424-31. PubMed ID: 27054279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.
    Pardons M; Baxter AE; Massanella M; Pagliuzza A; Fromentin R; Dufour C; Leyre L; Routy JP; Kaufmann DE; Chomont N
    PLoS Pathog; 2019 Feb; 15(2):e1007619. PubMed ID: 30811499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
    Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
    mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.
    Charlins P; Schmitt K; Remling-Mulder L; Hogan LE; Hanhauser E; Hobbs KS; Hecht F; Deeks SG; Henrich TJ; Akkina R
    Virology; 2017 Jul; 507():135-139. PubMed ID: 28432928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
    Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
    PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.
    Avalos CR; Price SL; Forsyth ER; Pin JN; Shirk EN; Bullock BT; Queen SE; Li M; Gellerup D; O'Connor SL; Zink MC; Mankowski JL; Gama L; Clements JE
    J Virol; 2016 Jun; 90(12):5643-5656. PubMed ID: 27030272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.
    Laird GM; Rosenbloom DI; Lai J; Siliciano RF; Siliciano JD
    Methods Mol Biol; 2016; 1354():239-53. PubMed ID: 26714716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
    Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption.
    de Goede AL; van Deutekom HW; Vrancken B; Schutten M; Allard SD; van Baalen CA; Osterhaus AD; Thielemans K; Aerts JL; Keşmir C; Lemey P; Gruters RA
    AIDS; 2013 Nov; 27(17):2679-89. PubMed ID: 24149085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy.
    Jones LE; Perelson AS
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):483-93. PubMed ID: 17496565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.
    Lassen KG; Ramyar KX; Bailey JR; Zhou Y; Siliciano RF
    PLoS Pathog; 2006 Jul; 2(7):e68. PubMed ID: 16839202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved assays to measure and characterize the inducible HIV reservoir.
    Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
    EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.